We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Sanofi | BIT:SANF | Italy | Ordinary Share |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | 0 | EUR |
| Date | Time | Source | Headline |
|---|---|---|---|
| 09/1/2025 | 06:00 | UKREG | Communiqué de presse : La nouvelle formulation sous-cutanée du Sarclisa a.. |
| 09/1/2025 | 06:00 | UKREG | Press Release: New Sarclisa subcutaneous formulation met co-primary.. |
| 23/12/2024 | 06:00 | UKREG | Press Release: Sanofi initiates phase 3 program for PCV21 and expands.. |
| 23/12/2024 | 06:00 | UKREG | Communiqué de presse : Sanofi lance un programme de phase III pour son.. |
| 19/12/2024 | 17:00 | UKREG | Communiqué de presse - Jean-Paul Kress rejoint le Conseil d’administration.. |
| 19/12/2024 | 17:00 | UKREG | Presse release: Jean-Paul Kress to join Sanofi's Board of Directors |
| 17/12/2024 | 12:30 | UKREG | Press Release: Duvakitug positive phase 2b results demonstrate.. |
| 17/12/2024 | 12:30 | UKREG | Communiqué de presse : Les résultats positifs de phase IIb concernant le.. |
| 17/12/2024 | 06:30 | UKREG | Communiqué de presse : Mise en ligne du document « Q4 2024 Aide-mémoire » |
| 17/12/2024 | 06:30 | UKREG | Press Release: Availability of the Q4 2024 Aide-mémoire |
Sanofi (SANF) Share Charts1 Year Sanofi Chart |
|
1 Month Sanofi Chart |
Intraday Sanofi Chart |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
